Skip to main content
. 2020 Dec 15;21(24):9558. doi: 10.3390/ijms21249558

Figure 2.

Figure 2

VEGF-A serum levels. After 7 days, aflibercept treatment significantly (p < 0.05) decreased VEGFA serum levels in NPDR and PDR patients, compared to diabetic patients without signs of DR, and compared to untreated naïve NPDR and PDR groups. * p < 0.05 vs. CTRL; † naïve vs. aflibercept (afli) treatment.